Product Development

Expert Product Development That Gets You to Market Faster.

QualityHub’s product development consultants are the secret weapon behind successful launches in the medical device, pharmaceutical, combination product, and biologics industries. They bring clarity, speed, and precision to an otherwise complex and highly regulated process.

In the early stages, our experts shape the vision. They assess the market, identify unmet needs, and translate ideas into viable product concepts. When it’s time to develop, they’re in the trenches. For medical devices, they steer design controls, usability engineering, and risk management with laser focus. In pharma and biologics, they guide formulation, preclinical planning, and stability testing with the precision that only comes from deep industry experience. For combination products, they align drug and device components into one cohesive, compliant solution.

QualityHub consultants are regulatory navigators. Whether you’re facing the US FDA, the EU EMA, or another global agency, we craft the submission strategy, prepare the documentation, and defend your product with confidence. From 510(k)s and New Drug Applications (NDAs) to Biologics License Applications (BLAs) and CE marking, QualityHub makes sure your journey down the regulatory pathway is smooth and free of compliance potholes.

We also build and optimize Quality Management System (QMS) frameworks that pass audits and inspections with ease, and when it comes to a clinical strategy, our consultants help design trials that deliver results and ensure your data is clean, credible, and compelling.

When it’s time to scale, our consultants handle the transfer from lab bench to manufacturing floor. They troubleshoot scale-up, validate processes, and streamline the tech transfer so your product moves smoothly into commercial production. And when you’re ready to launch, they help build market access strategies that work.

Learn more about how QualityHub can support your product from cradle to grave by exploring our various services listed below.

QualityHub begins by helping companies define a viable product concept – one that meets market demand, satisfies regulatory expectations, and fits within technical constraints. This means performing competitive analyses to identify gaps and working closely with internal teams to refine the product’s intended use, user needs, and critical design features.

In medical devices, this includes developing user needs and converting them into design inputs in accordance with design control/design and development requirements and expectations, while for pharmaceutical and biologic products, it often involves selecting the optimal dosage form, delivery system, or formulation platform based on clinical requirements and stability constraints.

QualityHub also helps define target product profiles (TPPs), development timelines, resource plans, and go/no-go decision points, laying the groundwork for a development process that’s both agile and controlled.

In industries served by QualityHub, regulatory approval is not optional – it’s the gatekeeper to every market. Our product development consultants craft detailed regulatory strategies that align with a product’s risk classification, regional market goals, and development timeline.

For medical devices, we help determine whether a product qualifies for 510(k), De Novo, or PMA in the US, and assist in meeting MDR/IVDR requirements in the EU. For drugs and biologics, we assess whether an IND, NDA, BLA, or hybrid pathway is appropriate. And for combination products, we coordinate with the FDA’s Office of Combination Products to clarify the lead center – device or drug – and applicable regulatory requirements.

QualityHub consultants author and manage regulatory submissions, including pre-submissions (Q-Sub meetings), full dossiers, and responses to agency questions. This includes preparing everything from CMC documentation and clinical protocols to risk management files, clinical evaluation reports, and labeling reviews.

Every product must be developed under a robust quality system, but what that system looks like depends on the product type and where it’s manufactured. QualityHub assesses existing quality management systems – or builds them from the ground up – to ensure compliance with global regulations and standards including:

  • 21 CFR, Part 820 (US MedTech)
  • EU MDR/IVDR (EU MedTech)
  • ISO 13485:2016 (international MedTech)
  • 21 CFR, Parts 210/211 (US Pharmaceuticals)
  • 21 CFR, Part 600 (US Biologics)

Our consultants develop standard operating procedures (SOPs), work instructions, document control systems, and training programs that are sized right for your company. QualityHub also conducts mock audits and inspections and develop supplier qualification programs to prep companies for FDA investigators, EU notified bodies, and other regulatory reviews.

To bring a regulated product to market, you must prove that it works, is safe, and can be manufactured in a consistent way. QualityHub helps your company design and oversee all necessary testing programs, including:

  • For Medical Devices: Design verification and validation, biocompatibility testing (per ISO 10993-1:2018), electrical safety, electromagnetic capability (EMC), packaging validation, and software validation (per IEC 62304:2006)
  • For Pharmaceuticals and Biologics: Stability studies, dissolution testing, method validation, sterility testing, extractables/leachables, and impurity profiling

QualityHub also compiles and manages the full set of technical documentation required for submissions, audits, and post-market support, ranging from device master records (DMRs) and design history files (DHFs) to quality overall summaries (QOS) and chemistry, manufacturing, and controls (CMC) sections.

If clinical data is required, QualityHub can develop and execute a plan that’s both scientifically rigorous and meet regulatory requirements. We assist with protocol development, site selection, investigator engagement, and submissions to a US Institutional Review Board (IRB) or internationally to an Independent Ethics Committee (IEC).

For medical devices, this includes determining whether clinical data is needed under US or EU requirements and structuring a clinical evaluation plan accordingly. For drugs and biologics, it means designing clinical trials – Phases I, II, and III – with endpoints that demonstrate safety, efficacy, and real-world relevance.

QualityHub consultants also help ensure data integrity, and prepare key documents like Clinical Study Reports (CSRs), Clinical Evaluation Reports (CERs), and safety narratives. Our involvement ensures that clinical evidence meets regulatory standards and supports labeling, marketing, and reimbursement objectives.

A successful transition from research and development (R&D) to manufacturing is critical, but it’s also where companies often stumble. QualityHub can lead or support the transfer of processes, methods, and know-how from the lab to the production floor, whether it’s in-house or with a contract manufacturer.

Our experts can coordinate technology transfer documentation, batch record development, process validation protocols (IQ/OQ/PQ), and manufacturing readiness assessments. They troubleshoot scale-up issues, support equipment selection and facility qualification, and ensure that all manufacturing processes comply with current Good Manufacturing Practices (cGMPs).

For combination products, we work across both drug and device manufacturing streams to ensure the final product integrates seamlessly and meets all constituent requirements.

Contact Us